5 followers
Kymera is a clinical stage biopharmaceutical company focused on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body’s own natural protein degradation system.
Nello Mainolfi
Kura Oncology
17 followers
SpringWorks Therapeutics
5 followers
Summit Therapeutics
4 followers
Prime Medicine
3 followers
4D Molecular Therapeutics
3 followers
Pivot Bio
2 followers
Garuda Therapeutics
4 followers
Relay Therapeutics
1 follower
Matica Biotechnology
1 follower
Eikon Therapeutics
1 follower
Parse Biosciences
1 follower
Explore companies